An update on the multimodality of localized rectal cancer

被引：4

作者：

Artac, Mehmet ^{[1
]}

Korkmaz, Levent ^{[1
]}

El-Rayes, Bassel ^{[2
]}

Philip, Philip A. ^{[3
]}

机构：

[1] Necmettin Erbakan Univ, Meram Med Fac, Dept Med Oncol, Konya, Turkey

[2] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA

[3] Karmanos Canc Ctr, Dept Gastrointestinal Oncol, Detroit, MI USA

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2016年 / 108卷

关键词：

Rectal cancer; Locally advanced; Neo-adjuvant; Surgery; Chemo-radiotherapy; PHASE-III TRIAL; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; WILD-TYPE KRAS; PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; NEOADJUVANT CHEMORADIOTHERAPY;

D O I：

10.1016/j.critrevonc.2016.10.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

New strategies have reduced the local recurrence (LR) rate and extended the duration of overall survival (OS) in patients with localized rectal cancer (RC) in recent decades. The mainstay of curative treatment remains radical surgery; however, downsizing the tumor by neo-adjuvant chemo-radiotherapy and adjuvant cytotoxic therapy for systemic disease has shown significant additional benefit. The standardization of total mesorectal excision (TME), radiation treatment (RT) dose and fractionation, and optimal timing and sequencing of treatment modalities with the use of prolonged administration of fluoropyrimidine concurrent with RT have significantly decreased the rates of LR in locally advanced rectal cancer (LARC) patients. This review focuses on the optimization of multi-modality therapies in patients with localized RC. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：23 / 32

页数：10

共 50 条

[31] Rectal cancer: Neoadjuvant chemoradiotherapy
Roedel, Claus
Hofheinz, Ralf
Fokas, Emmanouil
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (04) : 629 - 639
[32] What treatments should be skipped or intensified in localized rectal cancer?
Glimelius, Bengt
FUTURE ONCOLOGY, 2018, 14 (04) : 313 - 318
[33] Neoadjuvant treatment for rectal cancer
Bachet, Jean-Baptiste
Benoist, Stephane
Mas, Leo
Huguet, Florence
BULLETIN DU CANCER, 2021, 108 (09) : 855 - 867
[34] Neoadjuvant Therapy for Rectal Cancer
Quezada-Diaz, Felipe F.
Smith, J. Joshua
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 31 (02) : 279 - 291
[35] Rectal cancer update: postneoadjuvant staging
Schaefer, Arnd-Oliver
RADIOLOGIE, 2023, 63 (06): : 451 - 456
[36] Current status of locally advanced rectal cancer therapy and future prospects
Koukourakis, Ioannis M.
Kouloulias, Vassilis
Tiniakos, Dina
Georgakopoulos, Ioannis
Zygogianni, Anna
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 186
[37] Toward the Non-surgical Management of Locally Advanced Rectal Cancer
Dewdney, Alice
Cunningham, David
CURRENT ONCOLOGY REPORTS, 2012, 14 (03) : 267 - 276
[38] The Neoadjuvant Treatment of Rectal Cancer: A Review
Nussbaum, Nathan
Altomare, Ivy
CURRENT ONCOLOGY REPORTS, 2015, 17 (03)
[39] Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
Li, Moying
Xiao, Qiyun
Venkatachalam, Nachiyappan
Hofheinz, Ralf-Dieter
Veldwijk, Marlon R.
Herskind, Carsten
Ebert, Matthias P.
Zhan, Tianzuo
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[40] Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
Yoo, Ri Na
Kim, Hyung Jin
ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (04): : 356 - 367

← 1 2 3 4 5 →